Home > Share Market > Stocks > Nectar lifescience > Financial Statements> NECLIFE Profit & Loss

Nectar Lifescience Ltd Financial Statements

Profit & Loss Statement of Nectar Lifescience Ltd

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 1,543 2,366 1,876 1,644
yoy growth (%) (35) 26.10 14.10 (1.90)
Raw materials (1,157) (1,859) (1,367) (1,154)
As % of sales 75 78.50 72.90 70.20
Employee costs (73) (81) (78) (79)
As % of sales 4.75 3.42 4.18 4.82
Other costs (204) (207) (195) (186)
As % of sales 13.20 8.75 10.40 11.30
Operating profit 109 220 236 224
OPM 7.07 9.28 12.60 13.70
Depreciation (60) (61) (64) (62)
Interest expense (112) (126) (115) (117)
Other income 3.79 4.36 6.04 22.70
Profit before tax (59) 37.50 62.70 67.40
Taxes 11.50 (5.70) (10) (12)
Tax rate (19) (15) (17) (18)
Minorities and other -- -- -- --
Adj. profit (48) 31.80 52.30 55.30
Exceptional items (25) -- -- --
Net profit (73) 31.80 52.30 55.30
yoy growth (%) (330) (39) (5.50) 2.02
NPM (4.70) 1.34 2.79 3.37

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000